Steve Carney talks to Mark Ashton and Mark Whittaker about Evotec and their approach to fragment-based drug discovery

Drug Discov Today. 2007 Oct;12(19-20):789-93. doi: 10.1016/j.drudis.2007.09.002.
No abstract available

Publication types

  • Interview

MeSH terms

  • Biotechnology / trends*
  • Chemistry, Pharmaceutical / trends*
  • Drug Design*
  • Drug Industry / methods*
  • Drug Industry / trends
  • Magnetic Resonance Spectroscopy
  • Private Sector
  • Small Molecule Libraries*
  • Structure-Activity Relationship

Substances

  • Small Molecule Libraries